Company: BSAAR
Filing Date: 2025-01-10
Form Type: DRS
Source: 0001213900-25-002596
Chunk: 75

Company: BEST SPAC I Acquisition Corp.
Filing Date: 2025-01-10
Form: DRS
Chunk 75
---
 required for an overseas offering by a company affiliated with Chinese businesses or persons or a business combination with a target business based in and primarily operating in China. See page 87 for additional information. •Given the Chinese government’s significant oversight and discretion over the search for a target company, the CSRC and other PRC government agencies may exert more oversight and control over offerings that are conducted overseas and foreign investment in China -basedissuers. As a result, we face uncertainty about future actions by the PRC government that could significantly affect our ability to offer or continue to offer securities to investors and cause the value of our securities to significantly decline or be worthless. See page 89 for additional information. •If we become directly subject to the recent scrutiny, criticism and negative publicity involving US -listedChinese companies, we may have to expend significant resources to investigate and resolve the matter which could harm our business operations, this offering and our reputation and could result in a loss of your investment in our securities, especially if such matter cannot be addressed and resolved favorably. See page 91 for additional information. •We may not be able to complete an initial business combination with a U.S. target company since such initial business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited. See page 92 for additional information. 41 •Trading in our securities may be prohibited under the HFCAA if the PCAOB determines that it cannot inspect or fully investigate our auditor. In that case, Nasdaq would delist our securities. The delisting of our securities, or the threat of their being delisted, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections may deprive our investors with the benefits of such inspections. See page 92 for additional information. •We believe that the approval of the CSRC is not required in connection with this offering; however, if required, we cannot predict whether we will be able to obtain such approval. See page 97 for additional information. •Uncertainties with respect to the PRC legal system could adversely affect us. See page 97 for additional information. •Changes in China’s economic, political or social conditions or government policies could have a material adverse effect on us and/or the PRC target company’s business and results of operations we may pursue in the future. See page 98 for additional information. •You may